Otlertuzumab
Otlertuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Otlertuzumab is under investigation in clinical trial NCT01188681 (Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia).
| Trade Name | Otlertuzumab |
| Generic | Otlertuzumab |
| Otlertuzumab Other Names | Immunoglobulin, anti-(human cd antigen cd37) (synthetic human-mus musculus fragment tru-016), dimer, Otlertuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Otlertuzumab
